Clinical Trials Logo

Clinical Trial Summary

This study was conducted to compare the significance of lymph node ratio and absolute count of positive lymph node count on overall survival in patients with rectal cancer who underwent resection with curative intent


Clinical Trial Description

Retrospective cohort study carried on 229 patients with non-metastatic rectal cancer, admitted in tertiary hospitals along 10 years, between 2012 to 2022, and underwent radical resection surgery with curative intent. Exclusion criteria included patients with familial adenomatous polyposis, multiple synchronous or metachronous rectal cancers, early post-operative recurrence or death within 3 months. Demographic, histopathological, follow up and outcome data were collected. Demographics included age, gender, family history, and chief complaint at presentation. Histopathological data included tumor site, grade, vascular-perineural invasion, total number of lymph nodes removed, and positive lymph nodes. Lymph node ratio was defined as the ratio of positive lymph nodes to the total number of retrieved lymph nodes in histopathology specimen. Survival was calculated for each patient based on time of surgery to time of death Statistical analysis will be used to evaluate the effect of lymph node ratio on overall survival. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05667259
Study type Observational
Source South Valley University
Contact
Status Completed
Phase
Start date January 1, 2012
Completion date December 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT03628248 - Effect of Endovascular Inferior Mesenteric Artery Embolization on Colonic Perfusion Prior to Rectal Surgery for Rectal Tumor or Sigmoid Colon Surgery N/A
Not yet recruiting NCT05154474 - Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Not yet recruiting NCT04790227 - MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer
Completed NCT03688906 - AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Completed NCT04401787 - Converted Laparoscopic Resection of Upper Rectal Carcinoma T1-4 N0-1 in Obese Patients. N/A
Recruiting NCT05646043 - PREHAB - Improving Condition Before Surgery N/A
Recruiting NCT02533271 - Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer Phase 3